Endothelium-dependent hyperpolarization as a remote anti-atherogenic mechanism

Trends in Pharmacological Sciences

Volumn 23, Issue 5, 2002, Pages 213-220

  Selemidis, Stavros ^a   Cocks, Thomas M ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

EPOXYICOSATRIENOIC ACID; NITRIC OXIDE; PROSTACYCLIN; REACTIVE OXYGEN METABOLITE; SUPEROXIDE;

ATHEROGENESIS; ATHEROSCLEROSIS; BLOOD FLOW; BLOOD VESSEL INJURY; CELL DAMAGE; CELL PROTECTION; DRUG MECHANISM; ENDOTHELIUM; ENDOTHELIUM CELL; HEART PROTECTION; HUMAN; HYPERPOLARIZATION; HYPOTHESIS; INFLAMMATORY CELL; INHIBITION KINETICS; NONHUMAN; PRIORITY JOURNAL; REVIEW; SHEAR STRESS; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; THROMBOCYTE; THROMBOCYTE AGGREGATION; THROMBOGENESIS; VASODILATATION; VESSEL;

ANIMALS; ARTERIOSCLEROSIS; BLOOD PLATELETS; CALCIUM; ENDOTHELIUM, VASCULAR; HUMANS; NITRIC OXIDE; REACTIVE OXYGEN SPECIES;

EID: 0036569691     PISSN: 01656147     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-6147(02)01998-3     Document Type: Review

References (85)

1. Nitric oxide in the pathogenesis of vascular disease
2. Elevation of intracellular calcium in smooth muscle causes endothelial cell generation of NO in arterioles
3. An indirect influence of phenylephrine on the release of endothelium-derived vasodilators in rat small mesenteric artery
4. Endothelium-dependent hyperpolarization: A role in the control of vascular tone
5. The alternative: EDHF
6. EDHF and residual NO: Different factors
7. Prologue: EDHF - what is it?
8. + is an endothelium-derived hyperpolarizing factor in rat arteries
9. Cytochrome P450 2C is an EDHF synthase in coronary arteries
10. Endothelium-dependent hyperpolarization and intercellular electrical coupling in guinea-pig mesenteric arterioles
11. + but may be due to spread of current from the endothelium in guinea pig arterioles
12. Evidence for differential roles of nitric oxide (NO) and hyperpolarization in endothelium-dependent relaxation of pig isolated coronary artery
13. Role for endothelial cell conduction in ascending vasodilatation and exercise hyperaemia in hamster skeletal muscle
14. Myoendothelial and circumferential spread of endothelium-dependent hyperpolarization in coronary arteries
15. Endothelial cell pathway for conduction of hyperpolarization and vasodilation along hamster feed artery
16. Shear stress-induced vasodilation in porcine coronary conduit arteries is independent of nitric oxide release
17. Pulsatile stretch in coronary arteries elicits release of endothelium-derived hyperpolarizing factor: A modulator of arterial compliance
18. Role of the intima in cholinergic and purinergic relaxation of isolated canine femoral arteries
19. Endothelium-dependent relaxation of coronary arteries by noradrenaline and serotonin
20. The binding of high molecular weight kininogen to cultured human endothelial cells
21. High-molecular-weight kininogen is exclusively membrane bound on endothelial cells to influence activation of vascular endothelium
22. Endothelium derived relaxing factor
23. Differential actions of anadamide, potassium ions and endothelium-derived hyperpolarizing factor in guinea-pig basilar artery
24. Potassium ions and endothelium-derived hyperpolarizing factor in guinea-pig carotid and porcine coronary arteries
25. Information networks in the arterial wall
26. Morphology favors an endothelial cell pathway for longitudinal conduction within arterioles
27. Dye and electrical coupling of endothelial cells in situ
28. An intercellular regenerative calcium wave in porcine coronary artery endothelial cells in primary culture
29. Expression of multiple isoforms of nitric oxide synthase in normal and atherosclerotic vessels
30. Cellular and molecular mechanisms of endothelial cell dysfunction
31. Endothelial dysfunction in cardiovascular diseases: The role of oxidant stress
32. Mechanism of endothelium-dependent relaxation induced by substance P in the coronary artery of the pig
33. 2+ during acetylcholine-induced dilation of microvessels
34. Role of calcium/calmodulin-dependent protein kinase II in the regulation of vascular smooth muscle cell migration
35. Calcium, calmodulin and cell-cycle regulation
36. Calcium signalling and cell proliferation
37. Calcium regulation of gene expression: Isn't that spatial?
38. Calcium controls gene expression via three distinct pathways that can function independently of the Ras/mitogen-activated protein kinases (ERKs) signaling cascade
39. Calcium signalling in the cell nucleus
40. Role of L-type calcium channels on stimulated calcium influx and on proliferative activity of human coronary smooth muscle cells
41. Impact of nifedipine on vascular smooth muscle cell differentiation. Implications for atherogenesis
42. Review of preclinical data of calcium channel blockers and atherosclerosis
43. 2+
44. Coronary artery spasm does not depend on the intracellular calcium store but is substantially mediated by the protein kinase C-mediated pathway in a swine model with interleukin-1 beta in vivo
45. Platelet inhibition reduces cyclic flow variations and neointimal proliferation in normal and hypercholesterolemic-atherosclerotic canine coronary arteries
46. Frequency and severity of cyclic flow alternations and platelet aggregation predict the severity of neointimal proliferation following experimental coronary stenosis and endothelial injury
47. Anti-human von Willebrand factor monoclonal antibody AJvW-2 prevents thrombus deposition and neointima formation after balloon injury in guinea pigs
48. Pharmacological analysis of integrin function: Inhibition of vascular stenosis and identification of a novel antiplatelet substance
49. Effect of differential shear stress on platelet aggregation, surface thrombosis, and endothelialization of bilateral carotid-femoral grafts in the dog
50. Bradykinin stimulates tissue plasminogen activator release from human forearm vasculature through B2 receptor-dependent, NO synthase-independent, and cyclooxygenase-independent pathway
51. Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low-density-lipoprotein receptor-deficient mice
52. -/- mice reveals a role for chemokines in the initiation of atherosclerosis
53. The combined role of P- and E-selectins in atherosclerosis
54. Blocking very late antigen-4 integrin decreases leukocyte entry and fatty streak formation in mice fed an atherogenic diet
55. P-Selectin or intercellular adhesion molecule (ICAM)-1 deficiency substantially protects against atherosclerosis in apolipoprotein E-deficient mice
56. Endothelium-derived relaxing factor from cultured human endothelial cells inhibits aggregation of human platelets
57. Endothelium-derived relaxant factor inhibits platelet activation
58. Endogenous nitric oxide inhibits human platelet adhesion to vascular endothelium
59. Nitric oxide modulates the expression of monocyte chemoattractant protein 1 in cultured human endothelial cells
60. Inhibition of endothelial-derived nitric oxide promotes P-selectin expression and actions in the rat microcirculation
61. Nitric oxide protects against leukocyte-endothelium interactions in the early stages of hypercholesterolemia
62. Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines
63. Inhibition by nitric oxide and nitric oxide-producing vasodilators of DNA synthesis in vascular smooth muscle cells
64. Nitric oxide inhibits angiotensin II-induced migration of rat aortic smooth muscle cells. Role of cyclic nucleotides and angiotensin 1 receptors
65. Ionic channels in vascular endothelial cells
66. Ion channels and regulation of intracellular calcium in vascular endothelial cells
67. Calcium influx into endothelial cells and formation of endothelium-derived relaxing factor is controlled by the membrane potential
68. Anti-inflammatory properties of cytochrome P450 epoxygenase-derived eicosanoids
69. New role for epoxyeicosatrienoic acids as anti-inflammatory mediators
70. Oxidative stress as a regulator of gene expression in the vasculature
71. NAD(P)H oxidase: Role in cardiovascular biology and disease
72. Interactions of oxidants with vascular signaling systems
73. Novel role of NADH/NADPH oxidase-derived hydrogen peroxide in angiotensin II-induced hypertrophy of rat vascular smooth muscle cells
74. 2 for platelet-derived growth factor signal transduction
75. Stimulation of a vascular smooth muscle NAD(P)H oxidase by thrombin: Evidence that p47 (phox) may participate in forming this oxidase in vitro and in vivo
76. Endothelium-derived hyperpolarizing factor, but not nitric oxide or prostacyclin release, is resistant to menadione-induced oxidative stress in the bovine coronary artery
77. Ceramide reduces endothelium-dependent vasodilation by increasing superoxide production in small bovine coronary arteries
78. The small G-protein Rac mediates depolarization-induced superoxide formation in human endothelial cells
79. Vascular endothelium, hemodynamic forces, and atherogenesis
80. Coronary heart disease: Reducing the risk
81. Murine gamma-herpesvirus 68 causes severe large-vessel arteritis in mice lacking interferon-gamma responsiveness: A new model for virus-induced vascular disease
82. Inflammation, infection and antimicrobial therapy in coronary heart disease - where do we currently stand?
83. Alteration of endothelium-dependent hyperpolarizations in porcine coronary arteries with regenerated endothelium
84. Impaired hyperpolarization in regenerated endothelium after balloon catheter injury
85. Responses of inner and outer muscle of the sheep carotid artery to injury